knowledge -WSS

knowledge

author：entertainment 2025-09-28 21:05:02 - browse：849

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

WSS

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

He's a Nobel laureate. Critics say he was misleading on Covid

R1 RCM gets $5.8 billion buyout offer from private equity firm

The (many) problems with a new study criticizing cancer screening

R1 RCM gets $5.8 billion buyout offer from private equity firm

leisure time

knowledge

knowledge

Medicare details structure of new drug price negotiation program

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Heart attack and stroke risk calculators need revising

Ed Silverman on new gene therapies, biosimilars, coffee, and more

The cancer drug shortage isn’t new — and neither are the solutions

The (many) problems with a new study criticizing cancer screening

What does generative AI mean for health care? We asked experts

'Make People Better': The CRISPR babies story you probably don't know

Novavax promises a turnaround & Lilly roils the obesity market

Covid hospitalizations on the rise, Humana says

focus

What American doctors can learn from their Israeli counterparts

Snackable artificial intelligence, expert AI, and the pharma industry

ALS advocates say criticism of new drugs misses bigger picture

A new House health package & hospitals’ new site

What American doctors can learn from their Israeli counterparts

Medicare inequities exacerbate Puerto Rico’s health disparities

hotspot

focus

Wikipedia

leisure time